Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 13, 1983 - Issue 7
82
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Metabolism of imipramine in vitro: synthesis and characterization of N-hydroxydesmethylimipramine

, &
Pages 391-405 | Received 19 Jan 1983, Published online: 30 Sep 2009
 

Abstract

1. The synthesis of N-hydroxydesmethylimipramine via the corresponding primary hydroxylamine and oxime is described.

2. The N-oxygenated products are unstable to g.l.c. analysis without prior derivatization; the decomposition products are identified by g.l.c.-mass spectrometry.

3. N-Hydroxydesmethylimipramine is shown to be a metabolite of imipramine and desmethylimipramine on incubation of either with fortified 9000g liver homogenates of male New Zealand white rabbits. The metabolic product is characterized by mass spectrometry and n.m.r.

4. Didesmethylimipramine is shown to undergo metabolic α-C-oxidation, to yield the carboxylic acid, 3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propionic acid, but not N-oxidation.

5. N-Hydroxydesmethylimipramine is metabolically reduced to desmethylimipramine and metabolized further to 10-hydroxydesmethylimipramine, 2-hydroxydesmethylimipramine and the carboxylic acid.

6. The possible role of N-hydroxydesmethylimipramine and 3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propionic acid in the formation of iminodibenzyl is discussed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.